Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 13,555	$ 5,328
General and administrative	3,895	1,480
Total operating expenses	17,450	6,808
Loss from operations	(17,450)	(6,808)
Other income:
Interest income	56	8
Net loss	$ (17,394)	$ (6,800)
Net loss per share, basic and diluted	$ (0.66)	$ (1.93)
Weighted-average shares used to compute net loss per share, basic and diluted	26,511,743	3,530,975
Net loss	$ (17,394)	$ (6,800)
Other comprehensive loss:
Unrealized loss on short-term investments	(300)
Comprehensive loss	$ (17,694)	$ (6,800)